Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.2%

10 terminated/withdrawn out of 826 trials

Success Rate

92.8%

+6.3% vs industry average

Late-Stage Pipeline

12%

97 trials in Phase 3/4

Results Transparency

2%

3 of 129 completed trials have results

Key Signals

152 recruiting3 with results6 terminated4 withdrawn

Enrollment Performance

Analytics

N/A
252(49.3%)
Phase 2
127(24.9%)
Phase 4
65(12.7%)
Phase 3
32(6.3%)
Phase 1
25(4.9%)
Early Phase 1
10(2.0%)
511Total
N/A(252)
Phase 2(127)
Phase 4(65)
Phase 3(32)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (826)

Showing 20 of 826 trials
NCT07533825Not ApplicableEnrolling By Invitation

Laparoscopic Staging for Stage III Gastric Cancer

Role: collaborator

NCT07312526Completed

Shanghai Clinical Cohort - Esophageal Cancer

Role: collaborator

NCT07531368Not ApplicableNot Yet Recruiting

BBAP With CS Mapping Guidance

Role: lead

NCT07532122Completed

Postoperative Anxiety and Depression Among Chinese Elderly Patients

Role: collaborator

NCT07528105Early Phase 1Recruiting

Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes

Role: lead

NCT07529626Not Yet Recruiting

Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer

Role: lead

NCT07521787Not Yet Recruiting

Prognostic Value of Metabolic Characteristics in High-Risk Populations for Acute Kidney Injury After Cardiac Surgery

Role: lead

NCT07522164Active Not Recruiting

Acute Myocardial Infarction Clinical Cohort

Role: lead

NCT07519434Completed

AI-ECG for Time-Resolved Prediction of HFrEF

Role: lead

NCT07520123Not ApplicableNot Yet Recruiting

Union-FAST: An Intelligent-Agent Intervention to Increase Antiviral Treatment Uptake in Diagnosed-but-Untreated Hepatitis B Patients

Role: collaborator

NCT07517042Not ApplicableRecruiting

ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management

Role: lead

NCT07518680Not ApplicableNot Yet Recruiting

A Clinical Study on the Effect of Massaging Tian Tu Acupoint on Coughing After Esophageal Surgery

Role: lead

NCT07517653Phase 2Not Yet Recruiting

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

Role: lead

NCT07508956Phase 3Not Yet Recruiting

Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment

Role: lead

NCT07487532Not ApplicableNot Yet Recruiting

Acupuncture for Preventing Atrial Arrhythmia Recurrence After Ablation

Role: lead

NCT07502729Not Yet Recruiting

Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding

Role: lead

NCT06737913Phase 2Recruiting

HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma

Role: collaborator

NCT07501104Phase 2Not Yet Recruiting

Neoadjuvant Pucotenlimab Combined With Lenvatinib and Temozolomide in Resectable Stage IIB/III Acral Melanoma

Role: lead

NCT07494825Not ApplicableNot Yet Recruiting

CIED Post-OR Rehabilitation

Role: lead

NCT07493421Not ApplicableRecruiting

To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.

Role: collaborator